Evidence map›Paper›PMID 19122878›Full record

ArticleTransfusion alternatives in transfusion medicine : TATM2008

Blood viscosity modulates tissue perfusion: sometimes and somewhere.

C Lenz, A Rebel, K F Waschke, R C Koehler, T Frietsch

Open access · bronzeAbstract read
In one paragraph

Article in Transfusion alternatives in transfusion medicine : TATM, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Tetralogy of Fallot with concurrent patent foramen ovale and tricuspid valve dysplasia in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2018
    Article
  14. Article
  15. Proposed toxic and hypoxic impairment of a brainstem locus in autism.International journal of environmental research and public health · 2013
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

C LenzClinic of Anesthesiology and Critical Care Medicine, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
A Rebel
K F Waschke
R C Koehler
T Frietsch
Alfried Krupp Hospital · DEJohns Hopkins Medicine · USUniversity Hospital Heidelberg · DEUniversity Medical Centre Mannheim · DEUniversity of Kentucky · US

Funding

Cell-Free O2 Carriers: Cerebrovascular Control &StrokeR01NS038684 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KOEHLER, RAYMOND CHARLES · 2000 to 2014
$5.6M
NINDS NIH HHS R01 NS038684
6 · The paper itself

Abstract

Each organ possesses specific properties for controlling microvascular perfusion. Such specificity provides an opportunity to design transfusion fluids that target thrombo-embolic or vasospasm-induced ischemia in a particular organ or that optimize overall perfusion from systemic shock. The role of viscosity in the design of these fluids might be underestimated, because viscosity is rarely monitored or considered in critical care decisions. Studies linking viscosity-dependent changes of microvascular perfusion to outcome-relevant data suggest that whole blood viscosity is negligible as a determinant of microvascular perfusion under physiological conditions when autoregulation is effective. Because autoregulation is driven to maintain oxygen supply constant, the organism will compensate for changes in blood viscosity to sustain oxygen delivery. In contrast, under pathological conditions in the brain and elsewhere, increases of overall viscosity should be avoided - including all the situations where vascular autoregulatory mechanisms are inoperative due to ischemia, structural damage or physiologic dysfunction. As latter conditions are not to identify with high certainty, the risks that accompany therapeutic correction of blood viscosity are outweighing the benefits. The ability to bedside monitor blood viscosity and to link changes in viscosity to outcome parameters in various clinical conditions would provide more solid foundation for evidence-based clinical management.

Identifiers

PMID19122878
PMCPMC2519874
OpenAlexW2066308364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.